The IFG and BMI Department will jointly host Dr. Zhen Xu, Li Ka Shing Endowed Professor of Biomedical Engineering at the University of Michigan. Dr. Xu is a pioneer and world leader of histotripsy, a non-invasive, non-thermal, non-ionizing and non-radioactive technology developed for cancer, neurological, and cardiovascular applications. Her work has led to the FDA approval of histotripsy treatment of liver tumors. She has been elected as Fellow of National Academy of Inventors (NAI), Fellow of American Institute of Medicine and Bioengineering (AIMBE), and IEEE. 

Dr. Xu will talk about the mechanism and instrumentation of histotripsy, the latest pre-clinical and clinical progress, and her journey of bringing this technology from bench to bedside.